- testing |
Sector
PharmaceuticalsOpen
₹2,228Prev. Close
₹2,216.4Turnover(Lac.)
₹20,299.17Day's High
₹2,228Day's Low
₹2,17852 Week's High
₹3,054.852 Week's Low
₹2,115.1Book Value
₹375.77Face Value
₹1Mkt Cap (₹ Cr.)
90,936.83P/E
54.91EPS
40.36Divi. Yield
027 Oct 2025
12:00 AM
Board Meeting
Agenda : Audited Result
31 Jul 2025
12:00 AM
Dividend
Dividend Amount: 1
Record Date: 08 Aug, 2025
3 Jul 2025
12:00 AM
AGM
Announcement Date: 03 Jul, 2025
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 41.26 | 40.06 | 40.06 | 40.06 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 14,599.01 | 9,662.71 | 7,743.85 | 6,500.39 |
Net Worth | 14,640.27 | 9,702.77 | 7,783.91 | 6,540.45 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 12,207.44 | 10,260.44 | 8,749.43 | 7,781.56 | 6,214.43 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 12,207.44 | 10,260.44 | 8,749.43 | 7,781.56 | 6,214.43 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 553.56 | 296.41 | 140.99 | 210.48 | 182.63 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,799.5 | 92.3 | 4,31,412.42 | 564.22 | 0.89 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,417.5 | 67.76 | 1,70,343.22 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,728 | 59.13 | 1,26,185.41 | 597 | 0.16 | 2,707 | 249.83 |
Cipla Ltd CIPLA | 1,516.6 | 23.57 | 1,22,510.62 | 1,210.53 | 1.05 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,275.2 | 19.73 | 1,06,522.7 | 387.3 | 0.63 | 4,602.9 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Wholetime Director
RAMESH CHAND JUNEJA
Vice Chairman & Managing Director
RAJEEV JUNEJA
Whole Time Director & Chief Executive Officer
SHEETAL ARORA
Independent Director
TILOKCHAND PUNAMCHAND OSTWAL
Independent Director
Bharat Anand
Whole-time Director
SATISH KUMAR SHARMA
Independent Director
Vivek Kalra
Independent Director
Vijaya Sampath
Company Sec. & Compli. Officer
Hitesh Kumar Jain
208 Okhla Industrial Estate,
Phase-III,
New Delhi - 110020
Tel: 91-11-47476600
Website: http://www.mankindpharma.com
Email: investors@mankindpharma.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name Mankind Pharma Private Limited, by the Registrar of Companies, Delhi and Haryana, at New Delhi. Purs...
Read More
Reports by Mankind Pharma Ltd
What is the Mankind Pharma Ltd share price today?
What is the Market Cap of Mankind Pharma Ltd?
What is the PE and PB ratio of Mankind Pharma Ltd?
What is the 52 Week High and Low of Mankind Pharma Ltd?
What is the CAGR of Mankind Pharma Ltd?
What is the shareholding pattern of Mankind Pharma Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.